Osteonecrosis
54
5
10
23
Key Insights
Highlights
Success Rate
79% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
11.1%
6 terminated out of 54 trials
79.3%
-7.2% vs benchmark
11%
6 trials in Phase 3/4
30%
7 of 23 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 23 completed trials
Clinical Trials (54)
Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications
The Use of Genex in the Management of Early-Stage Osteonecrosis of the Femoral Head
Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral Head
Early Feasibility Study of Cartilage Defect Repair
Exactech Shoulder Post Market Clinical Follow-up Study
Effect of HBOT on Femoral Head Avascular Necrosis (AVN)
Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma
TESS V3 Modular Total Shoulder System PMCF
Sickle Cell Disease (SCD) Bone Pain Study
ACI-C Versus AMIC. A Randomized Trial Comparing Two Methods for Repair of Cartilage Defects in the Knee
Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI
In-vivo Wear Behaviour of AS Coated Versus Uncoated Columbus® Total Knee Prosthesis
Post-COVID-19 Sequelae: Osteonecrosis of Femoral Head
Randomized Clinical Trial for the Treatment of Osteonecrosis of the Femoral Head
MOTO Post-marketing Surveillance Study
PROMIS Evaluation Study
Meditation and Opioid Consumption in Total Joint Replacement Patients Undergo Primary Total Hip and Knee Replacement
A Comparison of Two Different Surgical Techniques in Hip Resurfacing Arthroplasty
Human Mesenchymal Stem Cells in the Synovial Fluid of the Hip